Callos Andrew bought CYTK

January 2, 2026 · Form 4 insider transaction

Callos Andrew bought 885 shares of Cytokinetics, Incorporated at $37.63 per share, a transaction worth $33.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.